Clinical Study

A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).

Posted Date: Sep 8, 2016

  • Investigator: Michael Thomas
  • Specialties:
  • Type of Study: Drug

This study is enrolling healthy females at least 18 years old with regular menstrual cycles who are seeking a birth control method for a year. The investigational birth control patch contains LNG (levonorgestrel) and EE (ethinyl estradiol), which are active ingredients in some Food and Drug Administration (FDA) approved birth control pills. The birth control patch looks like a round Band-Aid and is applied to the skin on the stomach, buttock or upper body. The drugs contained in the patch are absorbed through the skin. The patch is used in a 4-week (28-day) treatment cycle where a patch is applied and replaced every 7 days for 3 weeks in a row, followed by a 1-week “patch-free” period. The purpose of this study is to assess the effectiveness of the patch in preventing pregnancy, and to evaluate its safety and tolerability during a year of use in sexually active women who are using no other form of birth control.


This Study Is Enrolling Healthy Females At Least 18 Years Old With Regular Menstrual Cycles Who Are Seeking A Birth Control Method For A Year.


Women, Contraceptive, Pregnancy, Ob/Gyn, Birth Control

For More Information:

Jennifer Golan
(513) 584-4100